Advancing Bacteriophage Research: Proteon Pharmaceuticals opens the Center for Bacteriophage Biotechnology in Łódź
Łódź, 21 July 2023 – Proteon Pharmaceuticals opens the Center for Bacteriophage Biotechnology in Łódź Proteon Pharmaceuticals is delighted to announce the inauguration of its groundbreaking
Janusz Wojciechowski, EU Commissioner for Agriculture, visited Proteon Pharmaceuticals.
Łódź, 9 May 2022 – Janusz Wojciechowski, EU Commissioner for Agriculture, visited Proteon Pharmaceuticals today. Commissioner Wojciechowski’s visit to Proteon Pharmaceuticals is to get better acquainted
Proteon Pharmaceuticals Secures 21 million Euro to Accelerate Growth
Proteon Pharmaceuticals today announced an investment of 21 million Euro to accelerate commercialization of its products, which aim to reduce the reliance on antibiotics within aquaculture and livestock farming. Proteon Pharmaceuticals uses bacteriophages to reduce the need for antibiotics, improve on-farm performance and increase the sustainability of protein production.
EFSA confirms safety of BAFASAL®, A “First in Class”, innovative feed additive
PROTEON CONTINUES DIALOGUE WITH EU COMMISSION TO SECURE EARLY AUTHORIZATION In its first-ever evaluation of a bacteriophage feed additive, EFSA (European Food Safety Authority) concluded that BAFSAL® is safe for all avian species, consumers of derived poultry products, and does not pose a risk to the environment; The recognition of BAFASAL®’s safety by EFSA is
Proteon Pharmaceuticals announces a strategic partnership in distribution with DuPont Animal Nutrition
The partnership will bring the emerging bacteriophage technology to poultry producers to help mitigate antimicrobial resistance. Warsaw, September 9, 2020 – Proteon Pharmaceuticals, a Polish biotechnology company and leader in bacteriophage technology for livestock farming, today announced a strategic partnership with DuPont Animal Nutrition, a business unit of DuPont Nutrition & Biosciences (DuPont) in distribution